Shinpoong PharmaceuticalLtd (KOSE:A019175) - Stock Price, News & Analysis

A019175 Stock Overview

Manufactures and sells pharmaceutical products in South Korea. More details

A019175 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Earnings have declined by 68.7% per year over past 5 years

Shinpoong Pharmaceutical Co.,Ltd Competitors

BINEX

KOSDAQ:A053030

₩560.8b

Dong-A ST

KOSE:A170900

₩597.0b

JW Pharmaceutical

KOSE:A001060

₩587.6b

DongKook Pharmaceutical

KOSDAQ:A086450

₩724.2b

Price History & Performance

Summary of all time highs, changes and price drops for Shinpoong PharmaceuticalLtd
Historical stock prices
Current Share Price	₩17,770.00
52 Week High	₩39,400.00
52 Week Low	₩16,570.00
Beta	0.81
11 Month Change	-9.80%
3 Month Change	-39.25%
1 Year Change	-11.11%
33 Year Change	-68.88%
5 Year Change	210.12%
Change since IPO	838.64%

Recent updates

Shareholder Returns

	A019175	KR Pharmaceuticals	KR Market
7D	-7.9%	-9.0%	-6.0%
1Y	-11.1%	8.2%	-5.5%

Return vs Industry: A019175 underperformed the KR Pharmaceuticals industry which returned 8.2% over the past year.

Return vs Market: A019175 underperformed the KR Market which returned -5.5% over the past year.

Price Volatility

Is A019175's price volatile compared to industry and market?
A019175 volatility
A019175 Average Weekly Movement	4.7%
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	5.6%
10% most volatile stocks in KR Market	11.5%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A019175 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A019175's weekly volatility has decreased from 11% to 5% over the past year.

About the Company

Founded	Employees	CEO	Website
1962	828	Jei-Man Ryu	shinpoong.co.kr

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products.

Shinpoong Pharmaceutical Co.,Ltd Fundamentals Summary

How do Shinpoong PharmaceuticalLtd's earnings and revenue compare to its market cap?
A019175 fundamental statistics
Market cap	₩557.70b
Earnings (TTM)	-₩41.63b
Revenue (TTM)	₩208.78b

2.6x

P/S Ratio

-13.2x

P/E Ratio

Is A019175 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A019175 income statement (TTM)
Revenue	₩208.78b
Cost of Revenue	₩129.35b
Gross Profit	₩79.43b
Other Expenses	₩121.06b
Earnings	-₩41.63b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-812.13
Gross Margin	38.05%
Net Profit Margin	-19.94%
Debt/Equity Ratio	16.4%

How did A019175 perform over the long term?

See historical performance and comparison

Shinpoong PharmaceuticalLtd KOSE:A019175 Stock Report